STAT3 upregulates the protein expression and transcriptional activity of beta-catenin in breast cancer, Int J Clin Exp Pathol, vol.3, pp.654-664, 2010. ,
A novel mode of Gleevec binding is revealed by the structure of spleen tyrosine kinase, J Biol Chem, vol.279, pp.55827-55832, 2004. ,
The Protein Data Bank: a computer-based archival file for macromolecular structures, J Mol Biol, vol.112, pp.535-542, 1977. ,
Early man in western and northwestern Canada, Science, vol.89, pp.365-366, 1939. ,
A chemical biology approach identifies AMPK as a modulator of melanoma oncogene MITF, Oncogene, vol.33, pp.2531-2539, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-02168079
, Stat3 as an oncogene, vol.98, pp.295-303, 1999.
Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention, Clin Cancer Res, vol.8, pp.945-954, 2002. ,
A computational approach to analyze the mechanism of action of the kinase inhibitor bafetinib, PLoS Comput Biol, vol.6, p.1001001, 2010. ,
Triple-negative breast cancer: disease entity or title of convenience?, Nat Rev Clin Oncol, vol.7, pp.683-692, 2010. ,
Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3, Genes Dev, vol.13, pp.2604-2616, 1999. ,
Systems biology analysis of protein-drug interactions, Proteomics Clin Appl, vol.6, pp.102-116, 2012. ,
The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells, Nature, vol.406, pp.742-747, 2000. ,
Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors, Clin Cancer Res, vol.15, pp.110-118, 2009. ,
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups, Nature, vol.486, pp.346-352, 2012. ,
Inhibitors of protein kinase C. 2. Substituted bisindolylmaleimides with improved potency and selectivity, J Med Chem, vol.35, pp.994-1001, 1992. ,
Triple-negative breast cancer: clinical features and patterns of recurrence, Clin Cancer Res, vol.13, pp.4429-4434, 2007. ,
Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes, Nat Med, vol.17, pp.1514-1520, 2011. ,
, Tentler JJ Molecular Systems Biology, vol.11, p.789, 2015.
, Predictive Biomarkers of Sensitivity to the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Preclinical Breast Cancer Models, Clin Cancer Res, vol.19, pp.291-303
Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis, Clin Cancer Res, vol.9, pp.594-600, 2003. ,
Improved electrospray ionization efficiency compensates for diminished chromatographic resolution and enables proteomics analysis of tyrosine signaling in embryonic stem cells, Anal Chem, vol.81, pp.3440-3447, 2009. ,
Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy, Breast Cancer Res, vol.10, p.25, 2008. ,
Phase IIB trial of oral Midostaurin (PKC412), the FMS-like tyrosine kinase 3 receptor (FLT3) and multi-targeted kinase inhibitor, in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome with either wild-type or mutated FLT3, J Clin Oncol, vol.28, pp.4339-4345, 2010. ,
Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia, Blood, vol.115, pp.2578-2585, 2010. ,
Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells, Oncogene, vol.20, pp.2499-2513, 2001. ,
Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement, Ann Oncol, vol.23, pp.2997-3006, 2012. ,
Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer, J Clin Oncol, vol.24, pp.5652-5657, 2006. ,
Conformer generation with OMEGA: algorithm and validation using high quality structures from the Protein Databank and Cambridge Structural Database, J Chem Inf Model, vol.50, pp.572-584, 2010. ,
Conformer generation with OMEGA: learning from the data set and the analysis of failures, J Chem Inf Model, vol.52, pp.2919-2936, 2012. ,
Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics, Cancer Res, vol.69, pp.4116-4124, 2009. ,
The CD44+/CD24-phenotype is enriched in basal-like breast tumors, Breast Cancer Res, vol.10, p.53, 2008. ,
Systems biology of stem cells: three useful perspectives to help overcome the paradigm of linear pathways, Philos Trans R Soc Lond B Biol Sci, vol.366, pp.2247-2259, 2011. ,
Deletion of Stat3 blocks mammary gland involution and extends functional competence of the secretory epithelium in the absence of lactogenic stimuli, Endocrinology, vol.143, pp.3641-3650, 2002. ,
PI3K inhibition impairs BRCA1/2 expression and sensitizes BRCA-proficient triple-negative breast cancer to PARP inhibition, Cancer Discov, vol.2, pp.1036-1047, 2012. ,
Global cancer statistics, CA Cancer J Clin, vol.61, pp.69-90, 2011. ,
Walking the interactome for prioritization of candidate disease genes, Am J Hum Genet, vol.82, pp.949-958, 2008. ,
A large-scale analysis of tissue-specific pathology and gene expression of human disease genes and complexes, 2008. ,
, Proc Natl Acad Sci, vol.105, pp.20870-20875
Phosphoproteomic analysis of Syk kinase signaling in human cancer cells reveals its role in cell-cell adhesion, Oncogene, vol.28, pp.2337-2347, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00400163
The prognostic role of a gene signature from tumorigenic breast-cancer cells, N Engl J Med, vol.356, pp.217-226, 2007. ,
,
The JAK2/STAT3 signaling pathway is required for growth of CD44(+)CD24(-) stem cell-like breast cancer cells in human tumors, J Clin Invest, vol.121, pp.2723-2735, 2011. ,
Comparison of topological, shape, and docking methods in virtual screening, J Chem Inf Model, vol.47, pp.1504-1519, 2007. ,
Phase I study of PKC412 (N-benzoyl-staurosporine), a novel oral protein kinase C inhibitor, combined with gemcitabine and cisplatin in patients with non-small-cell lung cancer, Ann Oncol, vol.15, pp.316-323, 2004. ,
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes, Cancer Cell, vol.10, pp.515-527, 2006. ,
, , 1996.
, TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells, Genes Dev, vol.10, pp.2462-2477
Molecular portraits of human breast tumours, Nature, vol.406, pp.747-752, 2000. ,
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer, R68 ª, vol.12, pp.789-2015, 2010. ,
) Phase I and pharmacokinetic study of PKC412, an inhibitor of protein kinase C, J Clin Oncol, vol.19, pp.1485-1492, 2001. ,
Target profiling of small molecules by chemical proteomics, Nat Chem Biol, vol.5, pp.616-624, 2009. ,
Inhibiting aurora kinases reduces tumor growth and suppresses tumor recurrence after chemotherapy in patientderived triple-negative breast cancer xenografts, Mol Cancer Ther, vol.11, pp.2693-2703, 2012. ,
Non-oncogene addiction and the stress phenotype of cancer cells, Cell, vol.130, pp.986-988, 2007. ,
Aurora-A gene is frequently amplified in basal-like breast cancer, Oncol Rep, vol.23, pp.307-312, 2010. ,
Tumor suppressor function of Syk in human MCF10A in vitro and normal mouse mammary epithelium in vivo, PLoS One, vol.4, p.7445, 2009. ,
, Comprehensive molecular portraits of human breast tumours, Nature, vol.490, pp.61-70, 2012.
Tyrosine kinase SYK: essential functions for immunoreceptor signalling, Immunol Today, vol.21, pp.148-154, 2000. ,
Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression, Neoplasia, vol.11, pp.1318-1328, 2009. ,
Role of the protein tyrosine kinase Syk in regulating cell-cell adhesion and motility in breast cancer cells, Mol Cancer Res, vol.7, pp.634-644, 2009. ,
, License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited
, Molecular Systems Biology, vol.11, p.789, 2015.